Ocular drug delivery has constantly challenged ophthalmologists and drug delivery
scientists due to various anatomical and physiological barriers. Static and dynamic ocular …

Glaucoma is the second leading cause of blindness worldwide. Even though significant
advances have been made in its management, currently available antiglaucoma therapies …

Glaucoma is a group of diseases characterized by progressive degeneration of retinal
ganglion cells, leading to irreversible blindness. Currently, intraocular pressure reduction is …

Novel nanocarriers such as multifunctional nanoparticles (NPs) have recently attracted
attention due to their various applications, specifically in medicine and treatment. However, it …

Structural designing of carriers with extended drug release profiles is critically important for
achieving long-acting drug delivery systems toward efficient managements of chronic …

Glaucoma is considered a leading cause of blindness with the human eye being one of the
body's most delicate organs. Ocular diseases encompass diverse diseases affecting the …

Introduction Glaucoma is a chronic neurodegenerative disease, which is the leading cause
of irreversible blindness worldwide. As a response to high intraocular pressure, the clinical …

The key risk factor for glaucoma is increased intraocular pressure (IOP). Glaucoma drainage
devices implanted in the eye can reduce IOP and thus stop disease progression. However …

Glaucoma constitutes the second cause of blindness worldwide and it is considered a
neurodegenerative disorder. In this sense, Alzheimer's disease, which is the most common …

One of the lines of research on organic devices is focused on their miniaturization to obtain
denser and faster electronic circuits. The challenge is to build devices adding atom by atom …